GSK's former head of vaccines R&D – Dr Emmanuel Hanon – is heading up a new biotech called Vicebio that will go up against his former employer with a vaccine against respiratory syncytial virus (RSV) ...
A low-cost alternative for commonly used asthma medication will enter the market after pressure from Sen. Maggie Hassan.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results